The board announced that in order to maximize the opportunities that the company is facing, Trevor Bone will head up the UK operations to continue the good work the company has started nationally with the National Health System . Trevor will become the CEO of Medify Solutions Limited (UK), a wholly owned subsidiary of Medify Solutions Limited (US) having sole responsibility for all aspects of the company in relation to its operations in the UK and the National Health System .
Trevor will resign from the International operations and board, led by Medify Solutions Limited (US) which will create a wholly owned subsidiary, Medify International Ltd to manage and deliver the companies operations globally outside the UK. Jonathan Bryant will remain as Executive Chairman of Medify Solutions Limited (US) and will also lead the team of Medify International Ltd including the planned subsidiary floatation’s and the resultant shareholder share dividends.
Trevor Bone stated “The opportunity at this time within the UK means that working with partners and the National Health System to deliver the volume required needs total focus to ensure successful roll out. As there will now be an independent board to mange the parent company I can devote my energies to operational activities and achieving the levels of market penetration that we have always aimed for; delivery is the key”.
Jonathan Bryant, Executive Chairman, said: “Due to the demand for the company’s products and the complexities of the National Health System , it is imperative to best serve our customers and shareholders alike, we had to focus on the National Health System and UK operations with a dedicated team which knows, understands and can maximise our position. Trevor was the obvious and ideal person to lead this operation and accept the challenge as demonstrated by his track record and achievements to date. This is a very positive move and the right decision for the company. I am personally looking forward to the national success Trevor will bring to the company, which I have no doubt will be accelerated now he has a free hand to manage this business.”
Jonathan Bryant added: “This move also allows the company to focus its activities to manage external and internal business and allow Medify to grow into the corporate success we have planned. Simply, we now have our structure to manage the customer and business by territory, Medify Solutions (UK) and Medify International, and also a dedicated team to serve our shareholders and company personnel through Medify Solutions Limited, Delaware and International.”
Stay tuned: Italy’s Hot.
Sources:
M2 Communications, Ltd.
and
Medify Solutions Ltd.
For further information:
Jonathan Bryant, Group Chairman,
Medify Solutions,
Tel: +44(0)845-034-4090
jbryant@medifysolutions.com
About Medify Solutions, Inc.: The Medify Solutions group of companies are focused on the development, taking to market and delivery of leading edge mobile solutions for the healthcare market. With operations across the EU, Medify are at the forefront of the technology revolution in patient care. Medify Solutions are the first business to have developed a Secure Remote Access product for the Healthcare market – addressing critical requirements of Governmental strategic initiatives, Using the latest integrated mobile client based technologies.
Forward Looking Statements: This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words “estimate,” “project,” “intends,” “expects,” “believes,” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbour” provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see “Risk Factors” in the Company’s Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 453-4268. Web: StockGuru.com. Email: Publisher@stockguru.com.
Disclosure: Pentony Enterprises LLC was compensated $15,000 by a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.